目的:了解抗菌药物延迟处方策略(DAP)在呼吸道感染治疗中的应用进展,为其在我国卫生体系、尤其是在我国基层医疗机构中应用的可行性提供参考。方法:查阅PubMed、ProQuest Health & Medical Complete、Springer 等数据库,以DAP策略在呼吸道感染等疾病治疗中的应用进展为例,介绍DAP的定义及实施过程、DAP策略减少抗菌药物使用的原理和实施效果。结果与结论:DAP是一类患者根据病情进展而延迟使用的抗菌药物处方,其立足于在偏好敏感型决策场景下进行医患协同决策,进而有助于减少或避免使用抗菌药物。DAP策略在以英国为代表的高收入国家得到了很好的应用,并被纳入相关呼吸道感染临床指南中。但无论是从认知层面还是从效果层面,各国在实施DAP策略时仍存在分歧。建议未来相关学者加强对DAP策略在我国卫生系统应用的可行性研究,以促进我国抗菌药物合理应用。
Research progress of stimulus-responsive transdermal drug delivery systems
Recent advances on pharmacological effect and safety of Ampelopsis grossedentata
Comparative analysis of antibacterial drugs between the 2021 edition of WHO Model List of Essential Medicines for Children and the 2018 edition of National Essential Medicines List of China
我院2009-2011 年呼吸道感染患儿5 种常见细菌构成比及耐药性分析
Related Author
许红霞 韩海霞 杨少辉
LIANG Meijing
NING Hongxin
WANG Chuangchuang
LI Mengyi
HOU Wenbin
LI Yiliang
WANG Yang
Related Institution
College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Peking Union Medical College & Institute of Radiation Medicine, Chinese Academy of Medical Sciences
Shanghai Institute for Biomedical and Pharmaceutical Technologies/NHC Key Lab of Reproduction Regulation/Shanghai Engineer and Technology Research Center of Reproductive Health Drug and Devices
Dept. of Pharmacy, Tianjin Children’s Hospital/Tianjin University Children’s Hospital